Acute renal failure in HIV patients

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 2757-2762

  Izzedine, Hassane ^a   Baumelou, Alain ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Acute tubular necrosis; HAART; HIV

Indexed keywords

ABACAVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ATAZANAVIR; CREATININE; DIDANOSINE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 4; NEVIRAPINE; RITONAVIR; STAVUDINE; TENOFOVIR;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; AFRICAN AMERICAN; AGE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY INFECTION; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; UREMIA;

ADENINE; AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; PHOSPHONIC ACIDS;

EID: 36048982861     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm404     Document Type: Review

References (37)

1. Lameire N, Van BW, Vanholder R. Acute Kidney Injury. Lancet 2005; 365: 417-430
2. Nally JV. Acute renal failure in hospitalized patients. Cleveland Clinic J Med 2002; 69: 569-574
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal failure. Am J Kidney Dis 2002; 39: 930-936
4. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Kidney Injury Study Group. Kidney Int 1996; 50: 811-818
5. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIVassociated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139: 214-226
6. Perazella MA. Acute renal failure in HIV-infected patients: a brief review of common causes. Am J Med Sci 2000; 319: 385-391
7. Peraldi MN, Maslo C, Akposso K, Mougenot B, Rondeau E, Sraer JD. Acute renal failure in the course of HIV infection: a single institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant 1999; 14: 1578-1585
8. Kellum JA, Levin N, Bouman C et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002; 8: 509-514
9. Nochy D, Glotz D, Dosquet P et al. Renal lesions associated with human immunodeficiency virus infection: North American vs. European experience. Adv Nephrol Necker Hosp 1993; 22: 269-286
10. Franceschini N, Napravnik S, Eron JJ, Jr, Szczech LA, Finn WF. Incidence and etiology of acute renal failure among ambulatory HIVinfected patients. Kidney Int 2005; 67: 1526-1531
11. Wyatt CM, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 204561-204565
12. Rao TK, Friedman EA. Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 1995; 25: 390-398
13. Bourgoignie JJ, Meneses R, Ortiz C et al. The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 1988; 12: 131-137
14. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316: 1062-1068
15. Valeri A, Neusy AJ. Acute and chronic renal disease in hospitalized AIDS patients. Clin Nephrol 1991; 35: 110-118
16. Williams DI, Williams DJ, Williams IG et al. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm Infect 1998; 74: 179-184
17. Rockstroh JK, Mocroft A, Soriano V et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992-1002
18. Sulkowski MS, Moore RD, Mehta SH et al. Hepatitis C and progression of HIV disease. JAMA 2002; 288: 199-206, e
19. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831-837
20. Blaas S, Schneidewind A, Gluck T, Salzberger B. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases. AIDS 2006; 20: 1786-1787
21. Mehta RL, Pascual MT, Gruta CG et al. Refining predictive models in critically ill patients with Acute renal failure. |J Am Soc Nephrol 2002; 13: 1350-1357
22. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42: 1488-1495
23. Squires K, Pozniak AL, Pierone G, Jr et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Ann Intern Med 2003; 139: 313-320
24. Izzedine H, Hulot JS, Vittecoq D et al. Study 903 Team. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 2005; 20: 743-746
25. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS 2005; 19: 93-95
26. Buchacz K, Young B, Baker RK et al. The HIV Outpatient Study (HOPS) Investigators. Renal Function in Patients Receiving Tenofovir With Ritonavir/Lopinavir or Ritonavir/Atazanavir in the HIV Outpatient Study (HOPS) Cohort. J Acquir Immune Defic Syndr 2006; 43: 626-628
27. Scott J, Wolfe P, QUiros J et al. Rare occurrence of renal impairment when retrospectively evaluating the use of TDF in two clinical practises. XVè International AIDS conference 2004: poster no 4632
28. Horberg M, Klein D, Yu J et al. Effect of tenofovir on renal function in a "real world" clinic setting. XVè International AIDS Conference 2004: poster no We Pp 2066
29. Jaegel-Guedes E, Wolf E, Ruemmelein N et al. Incidence of tenofovir-related nephrotoxicity in a large outpatient cohort. XVè International AIDS Conference 2004: poster no B5937.
30. Jones R, Stebbing J, Nelson M et al. Renal Dysfunction with tenofovir DF containing HAART regimens is not observed more frequently: a cohort and case control study. J AIDS 2001; 37: 1489-1495
31. Lewis S, Gathe J, Wallace B et al. Comparative evaluation of renal function in HIV-infected treatment naï ve patients of African American descent receiving HAART regimens containing either ténofovir DF or Zidovudine. XVè International AIDS Conference 2004: poster no 4632.
32. Parish MA, Gallant JE and Moore R. Changes in renal function in patients treated with ténofovir DF vs nucleoside rverse transcriptase inhibitors. 11th CROI. 2004: poster no 751.
33. Day S, Date L, Hankins et al. Hypophosphophataemia in patients taking ténofovir. Brighton ans Sussex University Hospitals. 2003 Poster NHS Trust.
34. Lochet P, Peyriere H, Le Moing V, Blayac JP, Hansel S, Reynes J. Assessment of renal abnormalities in 107 HIV patients treated with tenofovir. Therapie 2005; 60: 175-181
35. Badiou S, De Boever CM, Terrier N, Baillat V, Cristol JP, Reynes J. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults? J Infect 2006; 52: 335-338
36. Izzedine H, Launay-Vacher V, Deray G. Renal tubular transporters and antiviral drugs: an update. AIDS 2005; 19: 455-462
37. Izzedine H, Hulot JS, Villard E et al. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis 2006; 194: 1481-1491